Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Journal of Endourology
|
October 16, 2025
Clinical Utility of Ureteral Optical Coherence Tomography for T Staging of Ureteral Cancer: NOCTURN Study
Makito Miyake, Takuto Shimizu, Nobutaka Nishimura, et al.
Japanese Journal of Clinical Oncology
|
December 9, 2022
Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study
Makito Miyake, Takuto Shimizu, Yuki Oda, et al.
International Journal of Clinical Oncology
|
August 27, 2022
First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer
Nobutaka Nishimura, Makito Miyake, Takuto Shimizu, et al.
European Heart Journal. Digital Health
|
March 20, 2024
Machine learning-based gait analysis to predict clinical frailty scale in elderly patients with heart failure
Yoshifumi Mizuguchi, Motoki Nakao, Toshiyuki Nagai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 19, 2019
Clinical benefit of early treatment with bone-modifying agents for preventing skeletal-related events in patients with genitourinary cancer with bone metastasis: A multi-institutional retrospective study
Takuya Owari, Makito Miyake, Yasushi Nakai, et al.
Journal of Bone Oncology
|
January 1, 2021
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
Takuya Owari, Makito Miyake, Yasushi Nakai, et al.
Methods and Protocols
|
August 28, 2024
A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial
Makito Miyake, Satoshi Anai, Yusuke Iemura, et al.
Cancer Management and Research
|
February 25, 2022
Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data
Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, et al.
Clinical Genitourinary Cancer
|
April 2, 2025
Impact of Initial Relative Dose Intensity on Tumor Response and Survival Outcomes in Enfortumab Vedotin Monotherapy for Previously Treated Advanced Urothelial Carcinoma: A Real-world Analysis From a Multicenter Study
Makito Miyake, Nobutaka Nishimura, Yusuke Iemura, et al.
Clinical Genitourinary Cancer
|
December 17, 2021
Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma
Makito Miyake, Takuto Shimizu, Nobutaka Nishimura, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Journal of Endourology
|
October 16, 2025
Clinical Utility of Ureteral Optical Coherence Tomography for T Staging of Ureteral Cancer: NOCTURN Study
Makito Miyake, Takuto Shimizu, Nobutaka Nishimura, et al.
Japanese Journal of Clinical Oncology
|
December 9, 2022
Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study
Makito Miyake, Takuto Shimizu, Yuki Oda, et al.
International Journal of Clinical Oncology
|
August 27, 2022
First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer
Nobutaka Nishimura, Makito Miyake, Takuto Shimizu, et al.
European Heart Journal. Digital Health
|
March 20, 2024
Machine learning-based gait analysis to predict clinical frailty scale in elderly patients with heart failure
Yoshifumi Mizuguchi, Motoki Nakao, Toshiyuki Nagai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 19, 2019
Clinical benefit of early treatment with bone-modifying agents for preventing skeletal-related events in patients with genitourinary cancer with bone metastasis: A multi-institutional retrospective study
Takuya Owari, Makito Miyake, Yasushi Nakai, et al.
Journal of Bone Oncology
|
January 1, 2021
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
Takuya Owari, Makito Miyake, Yasushi Nakai, et al.
Methods and Protocols
|
August 28, 2024
A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial
Makito Miyake, Satoshi Anai, Yusuke Iemura, et al.
Cancer Management and Research
|
February 25, 2022
Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data
Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, et al.
Clinical Genitourinary Cancer
|
April 2, 2025
Impact of Initial Relative Dose Intensity on Tumor Response and Survival Outcomes in Enfortumab Vedotin Monotherapy for Previously Treated Advanced Urothelial Carcinoma: A Real-world Analysis From a Multicenter Study
Makito Miyake, Nobutaka Nishimura, Yusuke Iemura, et al.
Clinical Genitourinary Cancer
|
December 17, 2021
Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma
Makito Miyake, Takuto Shimizu, Nobutaka Nishimura, et al.
Page
of 8